NCT01253421View on ClinicalTrials.gov

The Effects of Dopamine on Reward Processing

PHASE1CompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

amisulpride

single low-dose pharmacological challenge, 50 mg amisulpride

DRUG

placebo

single-dose placebo capsule

Trial Locations (1)

02478

McLean Hospital, Belmont

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Mclean Hospital

OTHER

NCT01253421 - The Effects of Dopamine on Reward Processing | Biotech Hunter | Biotech Hunter